<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: It has been reported that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning can induce neuroprotection, the mechanisms of which, however, are poorly elucidated </plain></SENT>
<SENT sid="1" pm="."><plain>We designed the present study to examine the hypothesis that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning could reduce <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>- reperfusion injury through up-regulating <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activities before ischemic injury by generating reactive oxygen species (ROS) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In preconditioning groups, adult male Sprague-Dawley rats were pretreated with 1 hour <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> exposure at a dose of 1%, 2%, or 4% for 5 consecutive days </plain></SENT>
<SENT sid="3" pm="."><plain>At 24 hours after the last exposure, <z:hpo ids='HP_0000001'>all</z:hpo> rats were subjected to focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 120 minutes followed by 72-hour reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>The role of ROS in ischemic tolerance was assessed by administration of the free radical scavenger dimethylthiourea and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi> before each preconditioning </plain></SENT>
<SENT sid="5" pm="."><plain>Brain ischemic injury was evaluated by neurologic behavior scores and brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume calculation </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="11" ids="22586">Antioxidant</z:chebi> enzyme activities (<z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, catalase, and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase [GSH-px]) of brain tissue and blood serum were tested at 24 hours after the last <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size and improved neurobehavioral outcome in a dose-dependent manner </plain></SENT>
<SENT sid="8" pm="."><plain>The neuroprotective effects of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning were abolished by dimethylthiourea and <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The activities of catalase and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GSH-px) in the brain tissue were elevated by <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning before ischemic injury </plain></SENT>
<SENT sid="10" pm="."><plain>The up-regulated activity of GSH-px in serum negatively correlated with brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume percentage </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning induces cerebral ischemic tolerance in a dose- response manner through ROS release and consequent up-regulation of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activity before ischemic injury in rats </plain></SENT>
<SENT sid="12" pm="."><plain>Serum GSH-px activity could be developed as a marker to assess the effectiveness of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>